G. Rodriguez

发表

A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.

G. Weiss, D. V. Von Hoff, H. Burris, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.

M. Saif, G. Rodriguez, M. Garcon, 2013, In vivo.

A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days

G. Weiss, D. V. Von Hoff, G. Clark, 1992, Anti-cancer drugs.

Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma.

G. Weiss, E. Raymond, D. V. Von Hoff, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.

K., M. Hidalgo, G. Weiss, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy.

M. Saif, Kristin Kaley, G. Rodriguez, 2013, JOP : Journal of the pancreas.

A Phase II Study of Trastuzumab-DM1 (T-DM1), a Novel HER2 Antibody–Drug Conjugate, in HER2+ Metastatic Breast Cancer (MBC) Patients Previously Treated with Conventional Chemotherapy, Lapatinib and Trastuzumab.

H. Rugo, P. LoRusso, L. Amler, 2009 .

A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

Suzanne F. Jones, D. V. Von Hoff, H. Burris, 1999, Cancer Chemotherapy and Pharmacology.

A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies.

D. V. Von Hoff, T. Petit, P. Ravdin, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.

G. Rodriguez, 1994, Investigational new drugs.

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.

G. Weiss, H. Burris, S. Kalter, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)

G. Weiss, D. V. Von Hoff, G. Clark, 1994, Anti-cancer drugs.

Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies.

M. Hidalgo, D. V. Von Hoff, G. Weiss, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks.

D. V. Von Hoff, H. Burris, S. Baker, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Ototoxicity associated with oxaliplatin in a patient with pancreatic cancer.

M. Saif, Sun-Young Oh, G. Rodriguez, 2013, JOP : Journal of the pancreas.

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.

H. Burris, F. A. Dorr, F A Dorr, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium.

G. Weiss, D. V. Von Hoff, L. Smetzer, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Mitomycin-C and capecitabine (MIXE) as salvage treatment in patients with refractory metastatic colorectal cancer: a retrospective study.

M. Saif, Kristin Kaley, G. Rodriguez, 2013, Anticancer research.

A phase I clinical and pharmacokinetic trial of hepsulfam.

J. Koeller, D. V. Von Hoff, P. Ravdin, 1991, Cancer research.

A Phase I Clinical and Pharmacokinetic Trial of Hepsulfam 1

P. Ravdin, D. V. Hoff, T. Brown, 2006 .

A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy.

M. Saif, Kristin Kaley, G. Rodriguez, 2013, JOP : Journal of the pancreas.